Immunopharmacological management of COVID-19: Potential therapeutic role of valproic acid

Med Hypotheses. 2020 Oct:143:109891. doi: 10.1016/j.mehy.2020.109891. Epub 2020 May 27.

Authors

Gokhan Unal¹, Bahadir Turan², Yasin Hasan Balcioglu³

Affiliations

¹ Department of Pharmacology, Faculty of Pharmacy, Erciyes University, Kayseri, Turkey.
² Autism, Mental Special Needs and Rare Diseases Department, Republic of Turkey Ministry of Health, Ankara, Turkey.
³ Department of Psychiatry, Bakirkoy Prof Mazhar Osman Training and Research Hospital for Psychiatry, Neurology, and Neurosurgery, Istanbul 34147, Turkey. Electronic address: yhasanbalcioglu@gmail.com.

No abstract available

Keywords: COVID-19; Cytokines; Immunomodulation; Immunopharmacology; Mood stabilizers; Valproic acid; Viral replication.

Publication types

Letter
Comment

MeSH terms

Antimanic Agents
Betacoronavirus
COVID-19
Coronavirus Infections*
Coronavirus*
Humans
Lithium
Pandemics*
Pneumonia, Viral*
SARS-CoV-2
Valproic Acid*

Substances

Antimanic Agents
Valproic Acid
Lithium